RecruitingNot ApplicableNCT05206838

Achilles Tendon for the Treatment of Gluteus Medius Insufficiency

Achilles Tendon Homograft for the Treatment of Gluteus Medius Insufficiency After Hip Replacement


Sponsor

Sahlgrenska University Hospital

Enrollment

44 participants

Start Date

Jun 29, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Residual limping after total hip arthroplasty is a serious complication that lacks effective treatment. The purpose of this study is to evaluate a surgical treatment for residual limping and compare its results with non-surgical treatment. Our hypothesis is that surgical treatment followed by physiotherapy increases hip function and reduces limping compared with non-surgical treatment with physiotherapy alone.


Eligibility

Min Age: 40 YearsMax Age: 80 Years

Inclusion Criteria4

  • Persisting limping with positive Trendelenburg's sign for at least 12 months after total hip arthroplasty
  • Rupture/avulsion of the gluteus medius tendon verified with ultrasound or MRI
  • Leg length discrepancy of less than 1 cm
  • Femoral offset discrepancy of less than 25%

Exclusion Criteria1

  • Neuromuscular disorders

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURESurgical reconstruction of gluteus medius with Achilles tendon allograft

Achilles tendon allograft i fixed between the gluteus medius muscle and the greater trochanter


Locations(1)

Sahlgrenska University Hospital

Mölndal, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05206838


Related Trials